Paul R. Schneider
EVP, General Counsel · Zymeworks Inc.
Individual
- 2026
- May 15, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Paul R. Schneider files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kenneth Galbraith - $3.34M in ZYME purchases and sales in the last 12 months
- Paul Andrew Moore - $721K in ZYME purchases and sales in the last 12 months
- Jeffrey T. L. Smith - $476K in ZYME purchases and sales in the last 12 months
- Adam Schayowitz - $358K in ZYME purchases and sales in the last 12 months
- Mark Hollywood - $139K in ZYME purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Paul R. Schneider?
Paul R. Schneider is a corporate insider, tracked as EVP, General Counsel of Zymeworks Inc. (ZYME). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Paul R. Schneider last file a Form 4?
The only primary Form 4 on record is dated 15 May 2026.